Table 2.
Comparison of workplace, income, and medication before and during the corona virus 19 (COVID-19) pandemic (n = 76).
| Workplace, income, and medication | Before pandemic | During pandemic | P Value |
|---|---|---|---|
| Work status, % (n) | |||
| Home office, flexible hours | 14.5 (11) | 32.9 (25) | .048 |
| Home office, restricted time | 2.6 (2) | 6.6 (5) | |
| Worked on the company’s physical space, flexible hours | 18.4 (14) | 7.9 (6) | |
| Worked on the company’s physical space, restricted time | 36.8 (28) | 6.6 (5) | |
| Not working | 27.6 (21) | 46.1 (35) | |
| Income (monthly, R$), % (n) | |||
| < 1 Minimal salary | 25.0 (19) | 36.8 (28) | .061 |
| 1–5 Minimal salary | 61.8 (47) | 48.7 (37) | |
| 5–10 Minimal salary | 9.2 (7) | 11.8 (9) | |
| > 10 Minimal salary | 3.9 (3) | 2.6 (2) | |
| Medication, % (n) | |||
| Stimulant | 25.0 (19) | 34.2 (26) | .013 |
| Antidepressant | 7.9 (6) | 5.3 (4) | |
| l-carnitine | 1.3 (1) | 1.3 (1) | |
| Stimulant + antidepressant | 32.9 (25) | 5.3 (4) | |
| Stimulant + l-carnitine | 3.9 (3) | 1.3 (1) | |
| Stimulant + antidepressant + l-carnitine | 7.9 (6) | 2.6 (2) | |
| None | 21.1 (16) | 7.9 (6) | |
| Did not stop or change dosage | 0 (0) | 42.1 (32) |
Minimal salary in Brazilian currency (R$, Reais). Wilcoxon (Z) test.